» Articles » PMID: 31504461

Causal Association Between Periodontitis and Hypertension: Evidence from Mendelian Randomization and a Randomized Controlled Trial of Non-surgical Periodontal Therapy

Abstract

Aims: Inflammation is an important driver of hypertension. Periodontitis is a chronic inflammatory disease, which could provide a mechanism for pro-hypertensive immune activation, but evidence of a causal relationship in humans is scarce. We aimed to investigate the nature of the association between periodontitis and hypertension.

Methods And Results: We performed a two-sample Mendelian randomization analysis in the ∼750 000 UK-Biobank/International Consortium of Blood Pressure-Genome-Wide Association Studies participants using single nucleotide polymorphisms (SNPs) in SIGLEC5, DEFA1A3, MTND1P5, and LOC107984137 loci GWAS-linked to periodontitis, to ascertain their effect on blood pressure (BP) estimates. This demonstrated a significant relationship between periodontitis-linked SNPs and BP phenotypes. We then performed a randomized intervention trial on the effects of treatment of periodontitis on BP. One hundred and one hypertensive patients with moderate/severe periodontitis were randomized to intensive periodontal treatment (IPT; sub- and supragingival scaling/chlorhexidine; n = 50) or control periodontal treatment (CPT; supragingival scaling; n = 51) with mean ambulatory 24-h (ABPM) systolic BP (SBP) as primary outcome. Intensive periodontal treatment improved periodontal status at 2 months, compared to CPT. This was accompanied by a substantial reduction in mean SBP in IPT compared to the CPT (mean difference of -11.1 mmHg; 95% CI 6.5-15.8; P < 0.001). Systolic BP reduction was correlated to periodontal status improvement. Diastolic BP and endothelial function (flow-mediated dilatation) were also improved by IPT. These cardiovascular changes were accompanied by reductions in circulating IFN-γ and IL-6 as well as activated (CD38+) and immunosenescent (CD57+CD28null) CD8+T cells, previously implicated in hypertension.

Conclusion: A causal relationship between periodontitis and BP was observed providing proof of concept for development of clinical trial in a large cohort of hypertensive patients. ClinicalTrials.gov: NCT02131922.

Citing Articles

Changes in Serum Inflammatory Markers and in Clinical Periodontal Condition After Non-Surgical Periodontal Treatment in Hypertensive Patients.

Arregoces F, Roa N, Velosa-Porras J, Rodriguez L, Merchan M, Poveda J Biomedicines. 2025; 13(2).

PMID: 40002786 PMC: 11853083. DOI: 10.3390/biomedicines13020374.


Effect of age and systemic inflammation on the association between severity of periodontitis and blood pressure in periodontitis patients.

Yang H, Qin Y, Geng J, Qu J, Cheng Q, Li K BMC Oral Health. 2025; 25(1):273.

PMID: 39984899 PMC: 11843814. DOI: 10.1186/s12903-025-05665-4.


Development of a machine learning model related to explore the association between heavy metal exposure and alveolar bone loss among US adults utilizing SHAP: a study based on NHANES 2015-2018.

Chen J BMC Public Health. 2025; 25(1):455.

PMID: 39905341 PMC: 11796195. DOI: 10.1186/s12889-025-21658-y.


Connection between oral health and chronic diseases.

Fu D, Shu X, Zhou G, Ji M, Liao G, Zou L MedComm (2020). 2025; 6(1):e70052.

PMID: 39811802 PMC: 11731113. DOI: 10.1002/mco2.70052.


Natural Antimicrobial Peptides and Their Synthetic Analogues for Effective Oral Microflora Control and Oral Infection Treatment-The Role of Ceragenins in the Development of New Therapeutic Methods.

Czarnowski M, Wnorowska U, Luckiewicz M, Dargiewicz E, Spalek J, Okla S Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770567 PMC: 11678171. DOI: 10.3390/ph17121725.


References
1.
Madhur M, Lob H, McCann L, Iwakura Y, Blinder Y, Guzik T . Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2009; 55(2):500-7. PMC: 2819301. DOI: 10.1161/HYPERTENSIONAHA.109.145094. View

2.
Osmenda G, Maciag J, Wilk G, Maciag A, Nowakowski D, Loster J . Treatment of denture-related stomatitis improves endothelial function assessed by flow-mediated vascular dilation. Arch Med Sci. 2017; 13(1):66-74. PMC: 5206372. DOI: 10.5114/aoms.2017.64715. View

3.
Manhiani M, Seth D, Banes-Berceli A, Satou R, Navar L, Brands M . The role of IL-6 in the physiologic versus hypertensive blood pressure actions of angiotensin II. Physiol Rep. 2015; 3(10). PMC: 4632961. DOI: 10.14814/phy2.12595. View

4.
Hausding M, Jurk K, Daub S, Kroller-Schon S, Stein J, Schwenk M . CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunction. Basic Res Cardiol. 2013; 108(6):386. DOI: 10.1007/s00395-013-0386-5. View

5.
Esler M, Krum H, Sobotka P, Schlaich M, Schmieder R, Bohm M . Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010; 376(9756):1903-9. DOI: 10.1016/S0140-6736(10)62039-9. View